Drug intelligence / Profile preview

travoprost

Development stage
Approved
Lead developer
Alcon
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Ophthalmic, Intracameral
01

Overview

Travoprost is a synthetic prostaglandin F2α analog and an ester prodrug used as an ophthalmic solution to lower elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. After administration as eye drops, it is absorbed through the cornea and hydrolyzed to its active free acid form. The active metabolite acts as a selective agonist at the prostaglandin F receptor (FP) in the eye, increasing aqueous humor outflow via both uveoscleral and trabecular meshwork pathways. This mechanism reduces intraocular pressure and helps prevent optic nerve damage associated with glaucoma. Travoprost is considered highly selective for its target receptor compared to other agents in its class[1][2][3][5][6][8].

Brand names
TravatanTravatan ZIzbaDuotraviDose TR
Other names
Travoprost implantTravoprost insertTravoprost intracameral implantIntracanalicular travoprost insertSustained release travoprost
02

Targets

PTGFR (Prostaglandin F2 alpha receptor)

Beyond the preview

Go deeper on travoprost.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on travoprost.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call